Feb 9, 2022
Ex-FDA interim chief Giroir rejoins biotech world with eyes on $50M fundraising for new infectious disease company.
Jul 7, 2021
https://investors.vaxart.com/news-releases/news-release-details/vaxart-announces-exclusive-worldwide-license-agreement-altesa
Recent Comments